Compile Data Set for Download or QSAR
Report error Found 462 Enz. Inhib. hit(s) with all data for entry = 10124
TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454208((Z)-3-fluoro-4-(3-(4-fluorophenyl)-1H- indol-1-yl)...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454208((Z)-3-fluoro-4-(3-(4-fluorophenyl)-1H- indol-1-yl)...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454209((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454209((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454210((Z)-4-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454210((Z)-4-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454211((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454211((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454212((Z)-methyl 1-(4-amino-2-fluorobut-2-en- 1-yl)-3-(3...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454212((Z)-methyl 1-(4-amino-2-fluorobut-2-en- 1-yl)-3-(3...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454213(US10717733, Compound 6 | US10717733, Compound 52 |...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454213(US10717733, Compound 6 | US10717733, Compound 52 |...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454214((Z)-methyl 1-(4-amino-2-fluorobut-2-en- 1-yl)-3-(3...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454214((Z)-methyl 1-(4-amino-2-fluorobut-2-en- 1-yl)-3-(3...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454215((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454215((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454216((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454216((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454217((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454217((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454218((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454218((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454219((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454219((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454220((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454220((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454221((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-2- methyl-3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454221((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-2- methyl-3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454222((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454222((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454223((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(dimet...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454223((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(dimet...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454224((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-2-met...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454224((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-2-met...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454225((Z)-1-(4-amino-2-fluorobut-2-en-l-yl)-2- methyl-3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454225((Z)-1-(4-amino-2-fluorobut-2-en-l-yl)-2- methyl-3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454226((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(5-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454226((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(5-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454227((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (5-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454227((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (5-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454228((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454228((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (3-(N,N-d...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454229((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454229((Z)-ethyl 1-(4-amino-2-fluorobut-2-en-1- yl)-3-(3-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454230((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (4-fluoro...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454230((Z)-1-(4-amino-2-fluorobut-2-en-1-yl)-3- (4-fluoro...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454231(ethyl (Z)-1-(4-amino-2-fluorobut-2-en-1- yl)-3-(4-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454231(ethyl (Z)-1-(4-amino-2-fluorobut-2-en-1- yl)-3-(4-...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetOxidized low-density lipoprotein receptor 1(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM454232((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM454232((Z)-3-(1-(4-amino-2-fluorobut-2-en-1-yl)- 2-methyl...)
Affinity DataIC50: 300nMAssay Description:LOX: The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 462 total ) | Next | Last >>
Jump to: